Lisa S. Poritz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa S. Poritz has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Arthur Berg
Penn State College of Medicine
7 shared publications - John P. Hegarty
Division of Colon and Rectal Surgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
6 shared publications Walter A. Koltun
6 shared publicationsWalter Koltun
6 shared publications- Zhenwu Lin
Pennsylvania State University, Hershey, PA, USA
6 shared publications - Ashley A. Kelly
Department of Surgery, Division of Colon and Rectal Surgery, Penn State Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, USA
5 shared publications
Latest Publications
- 1 June 2013
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 17 (6) , 1027-1031
Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis
- 1 June 2013
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 17 (6) , 1027-1031
Chronic Use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
669 Chronic use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
669 Chronic use of PPI and H2 Antagonists Decreases the Risk of Pouchitis After IPAA for Ulcerative Colitis
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
532 Ostomy Creation Significantly Increases ER Visits and Hospital Readmission After Colorectal Resection
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
532 Ostomy Creation Significantly Increases ER Visits and Hospital Readmission After Colorectal Resection
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
531 Mutation in ZO-1 is Associated With Protection From Familial Inflammatory Bowel Disease
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
531 Mutation in ZO-1 is Associated With Protection From Familial Inflammatory Bowel Disease
Tumor volume and percent positive lymph nodes as a predictor of 5-year survival in colorectal cancer
- 31 July 2011
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 213 (1) , 199-200
Reply
- 31 July 2011
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 213 (1) , 199-200
Reply
- 12 July 2011
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (10) , 2802-2809
Increase in the Tight Junction Protein Claudin-1 in Intestinal Inflammation
Background and Aims Studies have shown a decrease in key tight junction (TJ) proteins such as ZO-1 and occludin in both inflammatory bowel disease (IBD) and experimental models of inflammation. Our group has also shown an increase in claudin-1 in experimental colitis. Methods IEC-18 cells were treated with increasing doses of tumor necrosis factor alpha (TNFα). The TJ was assessed by transepithelial resistance (TER), permeability, Western blot, PCR, and immunofluorescence. Mucosal samples from patients with ulcerative colitis (UC), Crohn’s disease (CD), and without IBD (normal) were assayed for TJ proteins occludin and claudin-1 by Western blot and a ratio of claudin-1 to occludin (C:O) was calculated. Results IEC-18 cells had increased permeability, decreased TER and an increase in claudin-1 with TNFα treatment. In human specimens, there was a decrease in occludin and an increase in claudin-1 leading to a significant increase in the C:O ratio in diseased UC colon compared to non-diseased UC colon (P < 0.001) and normal colon (P < 0.01). In CD, the C:O ratio was similar in all CD tissue irrespective of disease status. Conclusions Treatment of IEC-18 cells with TNFα, a key inflammatory cytokine in IBD, led to a significant increase in claudin-1 expression. There was a significant increase in the C:O ratio in diseased colon in UC compared to the healthy appearing UC colon and normal controls. The C:O ratio was unchanged in CD despite presence or abscence of gross disease. This suggests that there may be an underlying difference in the TJ between UC and CD.
- 12 July 2011
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (10) , 2802-2809
Increase in the Tight Junction Protein Claudin-1 in Intestinal Inflammation
Background and Aims Studies have shown a decrease in key tight junction (TJ) proteins such as ZO-1 and occludin in both inflammatory bowel disease (IBD) and experimental models of inflammation. Our group has also shown an increase in claudin-1 in experimental colitis. Methods IEC-18 cells were treated with increasing doses of tumor necrosis factor alpha (TNFα). The TJ was assessed by transepithelial resistance (TER), permeability, Western blot, PCR, and immunofluorescence. Mucosal samples from patients with ulcerative colitis (UC), Crohn’s disease (CD), and without IBD (normal) were assayed for TJ proteins occludin and claudin-1 by Western blot and a ratio of claudin-1 to occludin (C:O) was calculated. Results IEC-18 cells had increased permeability, decreased TER and an increase in claudin-1 with TNFα treatment. In human specimens, there was a decrease in occludin and an increase in claudin-1 leading to a significant increase in the C:O ratio in diseased UC colon compared to non-diseased UC colon (P < 0.001) and normal colon (P < 0.01). In CD, the C:O ratio was similar in all CD tissue irrespective of disease status. Conclusions Treatment of IEC-18 cells with TNFα, a key inflammatory cytokine in IBD, led to a significant increase in claudin-1 expression. There was a significant increase in the C:O ratio in diseased colon in UC compared to the healthy appearing UC colon and normal controls. The C:O ratio was unchanged in CD despite presence or abscence of gross disease. This suggests that there may be an underlying difference in the TJ between UC and CD.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
PTPN2 is Associated With Crohn's Disease (CD) and Its Up-Regulation in CD Patients Mediated by Nkx2-3
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
PTPN2 is Associated With Crohn's Disease (CD) and Its Up-Regulation in CD Patients Mediated by Nkx2-3
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
NOD2 Mutation Results in Altered Wound Healing in Epithelial Cells
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
NOD2 Mutation Results in Altered Wound Healing in Epithelial Cells
- 1 August 2010
- Published by Elsevier in Journal of Surgical Research
- Vol. 162 (2) , 290-298
Impaired IL-4 Phosphorylation of STAT6 in EBV Transformed B-Cells
- 1 August 2010
- Published by Elsevier in Journal of Surgical Research
- Vol. 162 (2) , 290-298
Impaired IL-4 Phosphorylation of STAT6 in EBV Transformed B-Cells